[1]
A. Prasad, “Study of Prevalence Rate, Side Effect and Co-Morbidities Associated with Current Drug Therapy in Patients Suffering with Nephrotic Syndrome”, J. Drug Delivery Ther., vol. 9, no. 5-s, pp. 11–17, Oct. 2019, doi: 10.22270/jddt.v9i5-s.3589.